HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Federico Venuta Marco Anile Daniele Diso Mohsen Ibrahim Tiziano De Giacomo Giorgio F. Coloni Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Venuta, F. Articles by Coloni, G. F. Search for Related Content PubMed PubMed Citation Articles by Venuta, F. Articles by Coloni, G. F. Related Collections Lung - cancer

Eur J Cardiothorac Surg 2007;31:714-717. doi:10.1016/j.ejcts.2007.01.017
Copyright © 2007, European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved

Operative complications and early mortality after induction therapy for lung cancer

Cattedra di Chirurgia Toracica, Policlinico Umberto I, Università di Roma "La Sapienza", V.le del Policlinico, 00100 Rome, Italy

Received 28 September 2006; received in revised form 20 December 2006; accepted 15 January 2007.

^_* Corresponding author. Tel.: +39 06 4461971; fax: +39 06 49970735. (Email: sofed{at}libero.it).

Objective: Induction therapy for advanced lung cancer allows improvement of completeness of resection and survival. However, predictive risk factors for postoperative complications and early mortality remain controversial. We report our 14-year experience with this combined approach. Methods: One hundred and thirty-nine patients (100 males and 39 females) underwent induction therapy and surgery for stage IIIA and B lung cancer. The mean age was 58.4 ± 7.7 years. We retrospectively collected demographic data, preoperative functional parameters, type of operation, associated disorders, staging, induction regimen (chemotherapy alone or associated with radiotherapy). Univariate and multivariate analyses were performed to identify predictors of postoperative complications and early mortality. Results: One hundred and nine patients received chemotherapy (mainly based on cisplatin and gemcitabine) and 30 received chemoradiotherapy (median dose 50 Gy). Complications developed in 49 patients (35%). The most frequent was persistent air leakage (23–30% of the lobectomies), followed by cardiac complications, respiratory failure, and infections. Five patients (3.5%) died in the postoperative period and four of them had received pneumonectomy (mortality for pneumonectomy: 12.5%). The statistical analysis demonstrated that only pneumonectomy was associated with an increased mortality risk with no differences between intra- and extrapericardial dissection or right and left pneumonectomy. Conclusions: Induction therapy seems to be associated with an increased incidence of air leakage; the risk of other complications is acceptable. Pneumonectomy is associated with an increased risk of mortality and should be performed in selected patients.

Key Words: Lung cancer • Induction • Neoadjuvant therapy • Morbidity • Mortality

This article has been cited by other articles:

				F. Venuta, A. M. Ciccone, M. Anile, M. Ibrahim, T. De Giacomo, G. F. Coloni, and E. A. Rendina Reconstruction of the pulmonary artery for lung cancer: Long-term results J. Thorac. Cardiovasc. Surg., November 1, 2009; 138(5): 1185 - 1191. [Abstract] [Full Text] [PDF]

				I. Kappers, J. W. van Sandick, J. A. Burgers, J. S.A. Belderbos, M. W. Wouters, N. van Zandwijk, and H. M. Klomp Results of combined modality treatment in patients with non-small-cell lung cancer of the superior sulcus and the rationale for surgical resection Eur. J. Cardiothorac. Surg., October 1, 2009; 36(4): 741 - 746. [Abstract] [Full Text] [PDF]

				A. W. Kim, L. P. Faber, W. H. Warren, S. Basu, S. C. Wightman, J. A. Weber, P. Bonomi, and M. J. Liptay Pneumonectomy after chemoradiation therapy for non-small cell lung cancer: does "side" really matter? Ann. Thorac. Surg., September 1, 2009; 88(3): 937 - 943. [Abstract] [Full Text] [PDF]

				M. J. Krasna COUNTERPOINT: Pneumonectomy after chemoradiation: the risks of trimodality therapy. J. Thorac. Cardiovasc. Surg., August 1, 2009; 138(2): 295 - 299. [Abstract] [Full Text] [PDF]

				A. Brunelli, A. Charloux, C. T. Bolliger, G. Rocco, J-P. Sculier, G. Varela, M. Licker, M. K. Ferguson, C. Faivre-Finn, R. M. Huber, et al. ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy) Eur. Respir. J., July 1, 2009; 34(1): 17 - 41. [Abstract] [Full Text] [PDF]

				R. J. Cerfolio Editorial comment Eur. J. Cardiothorac. Surg., April 1, 2007; 31(4): 717 - 718. [Full Text] [PDF]